FIELD: medicine.
SUBSTANCE: treating respiratory distress syndrome accompanying neonatal ventilation is ensured by measuring glutathione peroxidase (GSH-Px-3) with underlying drug therapy, and the measured value being less than 2.41 mcmole/l requires including intravenous bolus injections of the preparation Selenase in a therapeutic complex at 10 mcg/kg/day, once a day for 10 days.
EFFECT: method provides increasing the survival rate in reducing a number of complications and a length of treatment by ensuring a lower severity of oxidative stress and a higher antioxidant protection of the body.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RESPIRATORY DISTRESS-SYNDROME THERAPY IN NEWBORN BABIES WHO ARE ON ARTIFICIAL LUNG VENTILATION | 2010 |
|
RU2434653C1 |
| METHOD OF TREATING RESPIRATORY DISTRESS SYNDROME IN NEWBORNS | 2009 |
|
RU2424001C1 |
| METHOD FOR PREDICTING THE RESULT OF RESPIRATORY DISTRESS-SYNDROME IN NEONATALS BEING UPON CONTROLLED VENTILATION | 2006 |
|
RU2311645C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF RESPIRATORY DISTRESS-SYNDROME IN NEONATALS | 1994 |
|
RU2089901C1 |
| METHOD FOR PREDICTING THE RESULT OF RESPIRATORY DISTRESS-SYNDROME IN NEONATALS IN CRITICAL STATE | 2006 |
|
RU2318445C1 |
| METHOD FOR PREDICTING RESPIRATORY DISTRESS SYNDROME OUTCOME IN NEWBORNS HAVING PERINATAL CENTRAL NERVOUS SYSTEM INJURY | 2006 |
|
RU2308724C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR BACTERIAL PNEUMONIA COMBINED WITH RESPIRATORY DISTRESS SYNDROME OF PREMATURE NEWBORN | 2008 |
|
RU2382362C1 |
| METHOD OF PREVENTING BRONCHOPULMONARY DYSPLASIA IN NEWBORN BABIES WITH VERY LOW AND EXTREMELY LOW BODY WEIGHT AT BIRTH | 2009 |
|
RU2416388C1 |
| METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN TREATING PNEUMONIA IN NEWBORNS WITH VERY LOW OR EXTREMELY LOW BODY WEIGHT | 2013 |
|
RU2525438C1 |
| METHOD OF PREDICTING BRONCHOPULMONARY DISPLASIA IN CHILDREN WITH INHERENT PNEUMONIA | 2010 |
|
RU2439569C1 |
